VolitionRx Limited issued a total of 779,371 shares of common stock to Lind Global Asset Management XII LLC between July and August 2026. These issuances satisfied payment obligations totaling $750,000 associated with senior secured convertible promissory notes originally issued under a securities purchase agreement dated May 15, 2025. The transactions were conducted in reliance on private placement exemptions and involved no paid commissions or public solicitation. VolitionRx Limited operates in the healthcare diagnostics industry, developing molecular diagnostic tests for cancer detection.
